Overview

Dr. Eman Abdulqadier Abdulrazaq is a Postdoctoral Fellow at KFSHRC specializing in translational oncology research. She holds a PhD in Molecular Medicine and Gene Analysis of Cancer and has extensive experience in cancer genomics, bioinformatics, and molecular diagnostics. Her work focuses on integrating multi-omics approaches, including whole exome sequencing and liquid biopsy, to understand cancer biology and improve early detection strategies.

Dr. Aldulrazaq is actively involved in precision oncology research, with particular interest in hereditary cancers, genomic instability, and biomarker discovery. She also contributes to the development of advanced molecular assays, including digital PCR-based approaches for disease monitoring, aligning her work with national priorities in precision medicine and Vision 2030.

Fields of Expertise

Cancer genomics and hereditary cancer genetics

Bioinformatics and multi-omics data analysis (WES, WGS, RNA-seq)

Molecular diagnostics and clinical variant interpretation (ACMG guidelines)

Digital PCR and advanced molecular assay development

Genomic instability and DNA repair mechanisms in cancer

Precision oncology and biomarker discovery

Next-generation sequencing (NGS) workflows and data interpretation

Career Background

Dr. Abdulrazaq earned her PhD in Molecular Medicine and Gene Analysis of Cancer from the University of Sharjah, UAE. Prior to her current role, she was involved in academic and research activities focusing on cancer genetics and molecular biology. She has over a decade of experience spanning molecular diagnostics, next-generation sequencing, and bioinformatics analysis. Her work includes both wet lab and computational approaches, contributing to studies in hereditary cancers, genomic instability, and biomarker discovery. She has also been engaged in mentoring students and supporting collaborative research projects, strengthening her interdisciplinary expertise in cancer research and precision medicine.
Beta Version